1. Home
  2. WAT vs FDS Comparison

WAT vs FDS Comparison

Compare WAT & FDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAT
  • FDS
  • Stock Information
  • Founded
  • WAT 1958
  • FDS 1978
  • Country
  • WAT United States
  • FDS United States
  • Employees
  • WAT N/A
  • FDS N/A
  • Industry
  • WAT Biotechnology: Laboratory Analytical Instruments
  • FDS Computer Software: Programming Data Processing
  • Sector
  • WAT Industrials
  • FDS Technology
  • Exchange
  • WAT Nasdaq
  • FDS Nasdaq
  • Market Cap
  • WAT 17.4B
  • FDS 17.6B
  • IPO Year
  • WAT 1995
  • FDS 1996
  • Fundamental
  • Price
  • WAT $378.00
  • FDS $263.70
  • Analyst Decision
  • WAT Buy
  • FDS Hold
  • Analyst Count
  • WAT 13
  • FDS 10
  • Target Price
  • WAT $379.00
  • FDS $356.78
  • AVG Volume (30 Days)
  • WAT 657.2K
  • FDS 836.9K
  • Earning Date
  • WAT 11-04-2025
  • FDS 12-18-2025
  • Dividend Yield
  • WAT N/A
  • FDS 1.66%
  • EPS Growth
  • WAT 3.82
  • FDS 11.79
  • EPS
  • WAT 10.88
  • FDS 15.55
  • Revenue
  • WAT $3,105,638,000.00
  • FDS $2,321,748,000.00
  • Revenue This Year
  • WAT $7.12
  • FDS $6.17
  • Revenue Next Year
  • WAT $6.22
  • FDS $5.44
  • P/E Ratio
  • WAT $34.80
  • FDS $17.05
  • Revenue Growth
  • WAT 6.90
  • FDS 5.39
  • 52 Week Low
  • WAT $275.05
  • FDS $250.50
  • 52 Week High
  • WAT $423.56
  • FDS $499.87
  • Technical
  • Relative Strength Index (RSI)
  • WAT 74.17
  • FDS 38.67
  • Support Level
  • WAT $340.09
  • FDS $250.50
  • Resistance Level
  • WAT $382.02
  • FDS $293.85
  • Average True Range (ATR)
  • WAT 10.45
  • FDS 7.88
  • MACD
  • WAT 1.74
  • FDS -0.01
  • Stochastic Oscillator
  • WAT 92.26
  • FDS 35.71

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

About FDS FactSet Research Systems Inc.

FactSet provides financial data and portfolio analytics to the global investment community. The company aggregates data from third-party data suppliers, news sources, exchanges, brokerages, and contributors into its workstations. In addition, it provides essential portfolio analytics that companies use to monitor portfolios and address reporting requirements. Buy-side clients (including wealth and corporate clients) account for roughly 82% of FactSet's annual subscription value. In 2015, the company acquired Portware, a provider of trade execution software. In 2017, it acquired BISAM, a risk management and performance measurement provider. In 2022, it completed its purchase of CUSIP Global Services.

Share on Social Networks: